Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
D000070:Acebutolol / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D001262:Atenolol / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000097:blood*; D007545:Isoproterenol / Q000037:antagonists & inhibitors*; D008297:Male; D008790:Metoprolol / Q000494:pharmacology; D010869:Pindolol / Q000494:pharmacology; D011217:Practolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012083:Renin / Q000097:blood*
D000319:Adrenergic beta-Antagonists; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D001262:Atenolol; D000070:Acebutolol; D011433:Propranolol; D010869:Pindolol; D012083:Renin; D008790:Metoprolol; D007545:Isoproterenol; D011217:Practolol